Advancements in Neurosurgical Oncology: Bridging Neurosurgery and Cancer Neuroscience
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Clinical Medicine, Cell, and Organism Physiology".
Deadline for manuscript submissions: 20 January 2025 | Viewed by 34
Special Issue Editor
2. Institute of Neurosciences of Castilla y León, Universidad de Salamanca, 37007 Salamanca, Spain
3. Latino America Valerio Foundation, Weston, FL 33331, USA
4. Memorial Cancer Institute, Memorial Healthcare System, Pembroke Pines, FL 33028, USA
Interests: cancer neuroscience; clinical oncology; neurosurgery; radiation oncology; radiosurgery; translational research; genetics and cancer; healthcare innovation and research
Special Issue Information
Dear Colleagues,
I am pleased to announce an upcoming Special Issue of our journal, dedicated to the latest advances in cancer neuroscience. It seeks to explore the profound interconnections between neural mechanisms and cancer pathology, offering insights into novel diagnostic tools, therapeutic strategies, and foundational science.
We aim to gather a diverse array of research articles, reviews, and brief reports that push the boundaries of our current understanding and clinical practices. Potential topics include, but are not limited to, the role of the nervous system in cancer development and progression, neuro-oncology, the impact of tumors on neural function, and innovative treatments targeting these intersections.
This Special Issue provides an excellent platform for researchers and clinicians to share their groundbreaking work with the global medical community. Contributions may address various aspects of neuroscience and oncology, including molecular pathways, clinical case studies, therapeutic trials, and translational research.
We would be honored if you could contribute your expertise and research findings to this Special Issue. For submission guidelines and further details, please refer to the journal’s submission page.
Join us in advancing the field of cancer neuroscience and making significant impacts on patient care and outcomes.
Dr. Andres M. Alvarez-Pinzon
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neuro-oncology
- cancer progression
- neural mechanisms in cancer
- brain tumors
- neurological implications of cancer
- cancer-induced neuropathy
- neural stem cells and cancer
- neuroinflammation in cancer
- neuroimaging in oncology
- cancer therapeutics and neurological safety
